Vaxxinity, Inc (VAXX) Misses Q3 EPS by 989c streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
CAPE CANAVERAL, Fla., Nov. 08, 2023 Vaxxinity, Inc. , a U.S. company pioneering the development of a new class of medicines, today reported financial results for the third quarter ended.
Vaxxinity Reports Third Quarter 2023 Financial Results and Provides Corporate Update eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.
Robert W. Baird initiated coverage on shares of Vaxxinity (NASDAQ:VAXX – Free Report) in a report issued on Thursday morning, Marketbeat reports. The brokerage issued an outperform rating and a $7.00 target price on the stock. Vaxxinity Price Performance Shares of Vaxxinity stock opened at $1.71 on Thursday. The company has a debt-to-equity ratio of […]